AstraZeneca Articles

Takeda posts strong profit growth for first-half 1999; Actos may be delayed

9 November 1999

GW seeks EU backing for Relenza prophylaxis

8 November 1999

Impact of American Home Products merger with Warner-Lambert on world ranking

4 November 1999

Stock Commentary Europe

4 November 1999

Stock Commentary Tokyo

4 November 1999

Flovent outperforms Accolate in asthma study

2 November 1999

Fujisawa lifts FY 2000 earnings forecasts

1 November 1999

AstraZeneca third-quarter profits grow 56% as Losec/Prilosec sales soar

28 October 1999

AstraZeneca partially divests two CV drugs

28 October 1999

AstraZeneca files new proton pump inhibitor - update

27 October 1999

AstraZeneca files new proton pump inhibitor

26 October 1999

FDA requests drug interaction data for Pfizer's Relpax

26 October 1999

"Rising tide" of pharma consolidation reviewed by banker

21 October 1999

AstraZeneca successfully defends omeprazole in Israeli court

21 October 1999

F&S launches reports on pain therapies, pediatric vaccines and generic GI

21 October 1999

Sangamo raises $7.5 million

18 October 1999

Flixotide gains first approval for COPD

14 October 1999

Stock Commentary Europe

14 October 1999

Scotia expanding Foscan trials as half-year losses deepen

13 October 1999

PDR developing "model license" forelectronic journals

12 October 1999

AstraZeneca pulls out of Muse deal

11 October 1999

UK's NICE turns nasty, rejecting Glaxo Wellcome's anti-flu drug Relenza

11 October 1999

Stock Commentary Europe

11 October 1999

Rhinocort Aqua approved in USA

11 October 1999

Incyte Pharmaceuticals shares plummet after profit warning is issued

11 October 1999

Raloxifene approval hots up osteoporosis treatment market

11 October 1999

Biogen Nordic operations, R&D center in USA

8 October 1999

Stock Commentary Europe

30 September 1999

Stock Commentary Europe

23 September 1999

Accolate approved for young children in USA

23 September 1999

BASF Pharma hoping to catch up with top pharmaceutical companies

23 September 1999

AstraZeneca files sNDA for metoprolol

22 September 1999

Knoll and AstraZeneca team up for obesity drug

16 September 1999

AstraZeneca launches Zomig rapimelt

16 September 1999

Arimidex hailed as tamoxifen successor

16 September 1999

Blow to AstraZeneca's defence of Losec

13 September 1999

AstraZeneca launches Zomig in China, Zoladex awarded Millennium Status

9 September 1999

2000 set to be a dramatic year for Japan's drug industry says Lehman

2 September 1999

Stock Commentary Europe

2 September 1999

One court to deal with Prilosec patent cases

24 August 1999

AstraZeneca's Atacand shows superiority over Merck's Cozaar

19 August 1999

AstraZeneca wins omeprazole injunction

19 August 1999

Eli Lilly's Evista shows efficacy in osteoporosis treatment

19 August 1999

Gensia Sicor gets court backing for propofol

16 August 1999

World's top-selling drugs; 2002 forecasts

13 August 1999

Stock Commentary Europe

12 August 1999

US managed care's favorite pharma cos

10 August 1999

Aventis clear leader in R&D pharma table, according to FT study

10 August 1999

BASF sees profits collapse as earnings are hit by vitamin price-fixing

6 August 1999

AstraZeneca's Pulmicort once-daily data

5 August 1999

AstraZeneca's strong health care sales drive group growth

4 August 1999

AstraZeneca's strong health care sales drive group growth

3 August 1999

Strong sales at Merck & Co push profits up 12% to $1.48 billion

27 July 1999

AstraZeneca an outperformer, say MSDW analysts

26 July 1999

Lilly ordered to stop false claims for Evista

22 July 1999

CIMA's Zomig OKed in Sweden, first appro

21 July 1999

Stock Commentary Europe

15 July 1999

AstraZeneca wins Losec injunction in Germany

8 July 1999

Funds flowed back into biotech in 2nd qtr 1999, says new study from Burrill

2 July 1999

Wyeth slashes UK price of Zoton

2 July 1999

AZ, Barr tamoxifen deal probed again

1 July 1999

Astra Zeneca opens new Zoladex plant

1 July 1999

Maxalt outperforms rival triptans

1 July 1999

AstraZeneca ends CytoTherapeutics deal

1 July 1999

AstraZeneca reveals three-year Pulmicort data in COPD

1 July 1999

High-dose Casodex launched in UK

24 June 1999

Stock Commentary Tokyo

24 June 1999

Stock Commentary Europe

24 June 1999

Euro pharma firms spell out plans for future growth to US investors

17 June 1999

Merck's Maxalt "More Effecttive" Than Competing Triptans

17 June 1999

Pharmacia & Upjohn set to acquire Sugen in $650 million stock deal

16 June 1999

Eli Lilly's Evista shows efficacy in breast cancer prevention

16 June 1999

NASBP study highlights tamoxifen triple therapy

16 June 1999

SmithKline Beecham on the verge of link-up with Novartis?

15 June 1999

US DTC Rx drug advertising reaches $1.5 billion in 12 months through March

9 June 1999

AstraZeneca to expand R&D in USA

9 June 1999

Rapid action of Zomig backed up by new study

4 June 1999

Stock Commentary New York

3 June 1999

US doctors to justify costly antipsychotics

2 June 1999

Close of AstraZeneca merger offers sees 99.6% acceptance

28 May 1999

Who, among drugmakers, gets the best press coverage in UK?

28 May 1999

Stock Commentary Europe

27 May 1999

Positive 1st-qtr news from AstraZeneca

26 May 1999

STAR trial gets underway

26 May 1999

New data supports promise of B-MS' omapatrilat in hypertension

25 May 1999

Strong net profits growth for Sankyo

24 May 1999

Goserelin may have place in early premenopausal breast cancer

20 May 1999

Aromasin cuts mortality in breast cancer

20 May 1999

Stock Commentary Europe

20 May 1999

Vivus signs $5 mill deal for MUSE in Japan

18 May 1999

Worst may to be over for Europe's pharma stocks, but analysts remain

14 May 1999

AstraZeneca in more wrangles over Losec

13 May 1999

Stock Commentary Europe

13 May 1999

Zeneca Specialties sell-off

13 May 1999

AstraZeneca sues Ratiopharm over Losec

10 May 1999

Stock Commentary Europe

6 May 1999

AstraZeneca sues Azupharma over Losec

6 May 1999

What's gone wrong with the European pharmaceutical industry - by Neil Turner

30 April 1999

AstraZeneca appointment in Japan

29 April 1999

"Price-fix" firms agree $148 million giveaway

27 April 1999

Showing 2601-2700 of 2730 articles

Go to beginningPreviousNextGo to end